These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 36539990)
1. Using imaging methods to assess severe calcinosis in juvenile dermatomyositis: A case report. Xu H; Wang L; Wei S; Li C; Yuan K Int J Rheum Dis; 2023 Mar; 26(3):554-558. PubMed ID: 36539990 [TBL] [Abstract][Full Text] [Related]
3. Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Bingham A; Mamyrova G; Rother KI; Oral E; Cochran E; Premkumar A; Kleiner D; James-Newton L; Targoff IN; Pandey JP; Carrick DM; Sebring N; O'Hanlon TP; Ruiz-Hidalgo M; Turner M; Gordon LB; Laborda J; Bauer SR; Blackshear PJ; Imundo L; Miller FW; Rider LG; Medicine (Baltimore); 2008 Mar; 87(2):70-86. PubMed ID: 18344805 [TBL] [Abstract][Full Text] [Related]
4. The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis. Hoeltzel MF; Oberle EJ; Robinson AB; Agarwal A; Rider LG Curr Rheumatol Rep; 2014 Dec; 16(12):467. PubMed ID: 25366934 [TBL] [Abstract][Full Text] [Related]
5. Local injection of infliximab into calcinosis lesions in patients with juvenile dermatomyositis (JDM): a clinical trial. Shiari R; Khalili M; Zeinali V; Shashaani N; Samami M; Moghaddamemami FH Pediatr Rheumatol Online J; 2024 Jan; 22(1):2. PubMed ID: 38166943 [TBL] [Abstract][Full Text] [Related]
6. Age-dependent inhibition of ectopic calcification: a possible role for fetuin-A and osteopontin in patients with juvenile dermatomyositis with calcinosis. Marhaug G; Shah V; Shroff R; Varsani H; Wedderburn LR; Pilkington CA; Brogan PA Rheumatology (Oxford); 2008 Jul; 47(7):1031-7. PubMed ID: 18448482 [TBL] [Abstract][Full Text] [Related]
7. Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications. Harel L; Harel G; Korenreich L; Straussberg R; Amir J J Rheumatol; 2001 May; 28(5):1129-32. PubMed ID: 11361202 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for developing calcinosis in juvenile dermatomyositis: subcutaneous and myofascial edema in initial magnetic resonance imaging. Yi BY; Marrs J; Acharya P; Sura A; Cidon M Rheumatol Int; 2024 Nov; 44(11):2577-2582. PubMed ID: 37432516 [TBL] [Abstract][Full Text] [Related]
10. Juvenile dermatomyositis forty years on: Case report. Rego de Figueiredo I; Guerreiro Castro S; Bernardino V; Silva Nunes J; Alves P; Moraes-Fontes MF Neuromuscul Disord; 2018 Sep; 28(9):791-797. PubMed ID: 30064892 [TBL] [Abstract][Full Text] [Related]
11. Calcinosis in juvenile dermatomyositis: a possible role for the vitamin K-dependent protein matrix Gla protein. van Summeren MJ; Spliet WG; van Royen-Kerkhof A; Vermeer C; Lilien M; Kuis W; Schurgers LJ Rheumatology (Oxford); 2008 Mar; 47(3):267-71. PubMed ID: 18234711 [TBL] [Abstract][Full Text] [Related]
13. Partial lipodystrophy associated with juvenile dermatomyositis: report of two cases. Quecedo E; Febrer I; Serrano G; Martinez-Aparicio A; Aliaga A Pediatr Dermatol; 1996; 13(6):477-82. PubMed ID: 8987057 [TBL] [Abstract][Full Text] [Related]
14. [Multi-center analysis of calcinosis in children with juvenile dermatomyositis]. Miyamae T; Mori M; Inamo Y; Kohno Y; Takei S; Maeda M; Murata T; Nakata S; Kawai H; Hirano Y; Date Y; Kitamura K; Yokota S Ryumachi; 2003 Jun; 43(3):538-43. PubMed ID: 12910962 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of probenecid for a patient with juvenile dermatomyositis complicated with calcinosis. Nakamura H; Kawakami A; Ida H; Ejima E; Origuchi T; Eguchi K J Rheumatol; 2006 Aug; 33(8):1691-3. PubMed ID: 16881125 [TBL] [Abstract][Full Text] [Related]
16. Hyperimmunoglobulin E syndrome with juvenile dermatomyositis and calcinosis. Saikia B; Aneja H; Jain J; Puliyel JM Clin Rheumatol; 2013 Mar; 32 Suppl 1():S51-3. PubMed ID: 20373123 [TBL] [Abstract][Full Text] [Related]
17. [Calcinosis and progressive lipodystrophy in the evolution of a dermatomyositis]. Marill FG; Hamra-Krouha MS Bull Soc Fr Dermatol Syphiligr; 1970; 77(6):893-9. PubMed ID: 5512051 [No Abstract] [Full Text] [Related]
18. Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset. Tansley SL; Betteridge ZE; Shaddick G; Gunawardena H; Arnold K; Wedderburn LR; McHugh NJ; Rheumatology (Oxford); 2014 Dec; 53(12):2204-8. PubMed ID: 24987158 [TBL] [Abstract][Full Text] [Related]
19. Recovery of Severe Muscular and Fascial Calcinosis After Treatment With Bisphosphonates in a Child With Juvenile Dermatomyositis. Cañas CA; Bonilla-Abadía F; Mejía M; Tobón GJ J Clin Rheumatol; 2015 Aug; 21(5):267-9. PubMed ID: 26203832 [TBL] [Abstract][Full Text] [Related]
20. Scrotum and testicular calcinosis in juvenile dermatomyositis (JDM). A report of two cases. Sallum AM; Garcia AJ; Saito OC; Silva CA Clin Exp Rheumatol; 2009; 27(2):382-3. PubMed ID: 19473587 [No Abstract] [Full Text] [Related] [Next] [New Search]